Irinotecan Orion 40 mg/2 ml, Infusionskonzentrat - Durchstechflasche(n) | | 59219001 | | Orion Pharma AG | | Irinotecan Orion 40 mg/2 ml, Infusionskonzentrat | | 11.09.2009 | | | | 11.09.2009 | | Irinotecan (L01XX19) | | | | WHO-DDD | | 10.09.2019 | | 07.16.10. | | Durchstechflasche(n) | | 07.16.10. | | | | A | | | | No | | | | IP | | | | 44.51 | | | | k.A. | | 67.45 | | FB | | | | 7680592190018 | | Synthetika human | | | | |
| Composition | irinotecani hydrochloridum trihydricum 40 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 2 ml. | Packungsbestandteile | | Concentrate for infusion | | |
| Source | Data was imported : 03.09.2014
Swissmedic Registration : 59219
Sequence : 01
Product name : Irinotecan Orion 40 mg/2 ml, Infusionskonzentrat
Registration owner: : Orion Pharma AG
Product group :
Index Therapeuticus (BSV) : 07.16.1.
Medication Code : Synthetika human
Date of registration : 11.09.2009
Valid until : 10.09.2019
Package number : 001
Show package size : 1
Commercial Form/Unit : Durchstechflasche(n)
Swissmedic categorie. : A
Active Agents : irinotecani hydrochloridum trihydricum
Composition : irinotecani hydrochloridum trihydricum 40 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 2 ml.
|
|
|